麦克尔病的药理和营养治疗试验。
Pharmacological and nutritional treatment trials in McArdle disease.
作者信息
Quinlivan R M, Beynon R J
机构信息
The Wolfson Centre for Inherited Neuromuscular Diseases (CIND), Robert Jones and Agnes Hunt, NHS Trust, Oswestry, UK.
出版信息
Acta Myol. 2007 Jul;26(1):58-60.
Abstract
A systematic review of evidence for randomised controlled trials using pharmacologic and nutritional therapies in McArdle disease was undertaken. Primary outcome measures included any objective assessment of exercise endurance. Secondary outcome measures included changes in metabolic parameters, subjective measures such as quality of life scores and adverse outcomes. Ten randomised controlled trials were identified. Two trials low dose creatine (60 mg/kg/day) and oral sucrose 75 g prior to exercise demonstrated a positive effect.
摘要
对使用药物和营养疗法治疗麦克尔迪氏病的随机对照试验证据进行了系统评价。主要结局指标包括对运动耐力的任何客观评估。次要结局指标包括代谢参数的变化、主观指标如生活质量评分和不良结局。共确定了10项随机对照试验。两项试验表明，运动前服用低剂量肌酸（60毫克/千克/天）和口服75克蔗糖有积极效果。
相似文献
1
Pharmacological and nutritional treatment trials in McArdle disease.
Acta Myol. 2007 Jul;26(1):58-60.
2
Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
Cochrane Database Syst Rev. 2004(3):CD003458. doi: 10.1002/14651858.CD003458.pub2.
3
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Cochrane Database Syst Rev. 2014 Nov 12;2014(11):CD003458. doi: 10.1002/14651858.CD003458.pub5.
4
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Cochrane Database Syst Rev. 2010 Dec 8(12):CD003458. doi: 10.1002/14651858.CD003458.pub4.
5
Creatine for treating muscle disorders.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD004760. doi: 10.1002/14651858.CD004760.pub2.
6
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Cochrane Database Syst Rev. 2008 Apr 16(2):CD003458. doi: 10.1002/14651858.CD003458.pub3.
7
Herbal and dietary therapies for primary and secondary dysmenorrhoea.
Cochrane Database Syst Rev. 2001(3):CD002124. doi: 10.1002/14651858.CD002124.
8
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
9
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. doi: 10.3310/hta10460.
10
Interventions for necrotizing soft tissue infections in adults.
Cochrane Database Syst Rev. 2018 May 31;5(5):CD011680. doi: 10.1002/14651858.CD011680.pub2.
引用本文的文献
1
Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.
J Neuromuscul Dis. 2021;8(3):401-417. doi: 10.3233/JND-200621.
2
McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Int J Mol Sci. 2019 Nov 25;20(23):5919. doi: 10.3390/ijms20235919.
3
Metabolic myopathy presenting with polyarteritis nodosa: a case report.
J Med Case Rep. 2011 Jun 30;5:262. doi: 10.1186/1752-1947-5-262.
本文引用的文献
1
Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
Cochrane Database Syst Rev. 2004(3):CD003458. doi: 10.1002/14651858.CD003458.pub2.
2
The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
N Engl J Med. 2003 Dec 25;349(26):2503-9. doi: 10.1056/NEJMoa031836.
3
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
Arch Neurol. 2002 Sep;59(9):1395-402. doi: 10.1001/archneur.59.9.1395.
4
Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.
Arch Neurol. 2002 Jan;59(1):97-101. doi: 10.1001/archneur.59.1.97.
5
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
Arch Neurol. 2000 Jul;57(7):956-63. doi: 10.1001/archneur.57.7.956.
6
Oral branched-chain amino acids do not improve exercise capacity in McArdle disease.
Neurology. 1998 Nov;51(5):1456-9. doi: 10.1212/wnl.51.5.1456.
7
Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study.
Neuromuscul Disord. 1998 May;8(3-4):210-2. doi: 10.1016/s0960-8966(98)00004-2.
8
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
J Clin Invest. 1998 Apr 15;101(8):1654-60. doi: 10.1172/JCI555.
9
Long-term creatine intake is beneficial to muscle performance during resistance training.
J Appl Physiol (1985). 1997 Dec;83(6):2055-63. doi: 10.1152/jappl.1997.83.6.2055.
10
A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies.
Muscle Nerve. 1997 Dec;20(12):1502-9. doi: 10.1002/(sici)1097-4598(199712)20:12<1502::aid-mus4>3.0.co;2-c.
Zotero 插件